Agitated behaviours associated with major neurocognitive disorders are currently addressed with antipsychotics and restraints that often don’t work and result in high human and economic costs.

MindfulGarden is the first clinically validated affective biofeedback platform created as a bedside tool for clinicians to manage neurocognitive behaviours, beginning with delirium. An acute change in the brain considered a medical emergency, delirium adds 3X to cost of care, and 9Xs risk of cognitive decline including earlier onset of dementia.

In clinical studies and real-world evaluations, MindfulGarden reduces ‘as needed’ antipsychotics and agitation, ultimately decreasing length of stay and cost of care.